JP2013518606A5 - - Google Patents

Download PDF

Info

Publication number
JP2013518606A5
JP2013518606A5 JP2012552935A JP2012552935A JP2013518606A5 JP 2013518606 A5 JP2013518606 A5 JP 2013518606A5 JP 2012552935 A JP2012552935 A JP 2012552935A JP 2012552935 A JP2012552935 A JP 2012552935A JP 2013518606 A5 JP2013518606 A5 JP 2013518606A5
Authority
JP
Japan
Prior art keywords
seq
sequence
cdr
amino acid
sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012552935A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013518606A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/024123 external-priority patent/WO2011100271A2/en
Publication of JP2013518606A publication Critical patent/JP2013518606A/ja
Publication of JP2013518606A5 publication Critical patent/JP2013518606A5/ja
Pending legal-status Critical Current

Links

JP2012552935A 2010-02-09 2011-02-09 新規使用 Pending JP2013518606A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30263610P 2010-02-09 2010-02-09
US61/302,636 2010-02-09
PCT/US2011/024123 WO2011100271A2 (en) 2010-02-09 2011-02-09 Novel uses

Publications (2)

Publication Number Publication Date
JP2013518606A JP2013518606A (ja) 2013-05-23
JP2013518606A5 true JP2013518606A5 (https=) 2013-12-05

Family

ID=44368403

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012552935A Pending JP2013518606A (ja) 2010-02-09 2011-02-09 新規使用

Country Status (5)

Country Link
US (1) US20120315267A1 (https=)
EP (1) EP2534256A4 (https=)
JP (1) JP2013518606A (https=)
CA (1) CA2789416A1 (https=)
WO (1) WO2011100271A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2892925T3 (es) 2006-03-31 2022-02-07 Chugai Pharmaceutical Co Ltd Métodos para controlar la farmacocinética en sangre de anticuerpos
CN101874042B9 (zh) 2007-09-26 2019-01-01 中外制药株式会社 利用cdr的氨基酸取代来改变抗体等电点的方法
KR102057826B1 (ko) 2008-04-11 2019-12-20 추가이 세이야쿠 가부시키가이샤 복수 분자의 항원에 반복 결합하는 항원 결합 분자
TWI812066B (zh) 2010-11-30 2023-08-11 日商中外製藥股份有限公司 具有鈣依存性的抗原結合能力之抗體
TW202237660A (zh) 2012-08-24 2022-10-01 日商中外製藥股份有限公司 FcγRIIb特異性Fc區域變異體
EP3597747B1 (en) 2012-08-24 2023-03-15 Chugai Seiyaku Kabushiki Kaisha Mouse fcgammarii-specific fc antibody
JO3580B1 (ar) * 2013-03-15 2020-07-05 Lilly Co Eli أجسام مضادة لكيموكين elr+ cxc شامل
WO2014146575A1 (en) * 2013-03-19 2014-09-25 Beijing Shenogen Pharma Group Ltd. Antibodies and methods for treating estrogen receptor-associated diseases
AU2014250434B2 (en) 2013-04-02 2019-08-08 Chugai Seiyaku Kabushiki Kaisha Fc region variant
EP2997042B1 (en) 2013-05-17 2019-08-07 Centre National de la Recherche Scientifique (CNRS) Anti-cxcl1, cxcl7 and cxcl8 antibodies and their applications
KR101860280B1 (ko) 2014-12-19 2018-05-21 추가이 세이야쿠 가부시키가이샤 항-마이오스타틴 항체, 변이체 Fc 영역을 함유하는 폴리펩타이드, 및 사용 방법
CN114773470A (zh) 2015-02-05 2022-07-22 中外制药株式会社 包含离子浓度依赖性的抗原结合结构域的抗体,fc区变体,il-8-结合抗体及其应用
US11359009B2 (en) 2015-12-25 2022-06-14 Chugai Seiyaku Kabushiki Kaisha Anti-myostatin antibodies and methods of use
TWI693940B (zh) * 2016-08-05 2020-05-21 日商中外製藥股份有限公司 Il-8相關疾病之治療用或預防用組成物
SG10201607778XA (en) 2016-09-16 2018-04-27 Chugai Pharmaceutical Co Ltd Anti-Dengue Virus Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use
EP3684811A2 (en) * 2017-08-17 2020-07-29 Massachusetts Institute of Technology Multiple specificity binders of cxc chemokines and uses thereof
CA3093729A1 (en) 2018-03-15 2019-09-19 Chugai Seiyaku Kabushiki Kaisha Anti-dengue virus antibodies having cross-reactivity to zika virus and methods of use
WO2020218465A1 (ja) * 2019-04-26 2020-10-29 中外製薬株式会社 子宮内膜症の診断方法、病態モニタリング方法及びキット
US12016846B2 (en) 2020-08-19 2024-06-25 University of Pittsburgh—of the Commonwealth System of Higher Education Methods of treating aneurysms
US12553904B2 (en) 2024-05-08 2026-02-17 University of Pittsburgh—of the Commonwealth System of Higher Education Methods of detecting and treating cerebral aneurysms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006063150A2 (en) * 2004-12-08 2006-06-15 Immunomedics, Inc. Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer
US7612181B2 (en) * 2005-08-19 2009-11-03 Abbott Laboratories Dual variable domain immunoglobulin and uses thereof
CL2008001071A1 (es) * 2007-04-17 2009-05-22 Smithkline Beecham Corp Metodo para obtener anticuerpo penta-especifico contra il-8/cxcl8, gro-alfa/cxcl1, gro-beta/cxcl2), gro-gama/cxcl3 y ena-78/cxcl5 humanas; anticuerpo penta-especifico; proceso de produccion del mismo; vector, hbridoma o celela que lo comprende; composicion farmceutica; uso para tratar copd, otras enfermedades.

Similar Documents

Publication Publication Date Title
JP2013518606A5 (https=)
JP2016185981A5 (https=)
JP2011087580A5 (https=)
JP2017114866A5 (https=)
JP2012528584A5 (https=)
HRP20150937T1 (hr) Pentaspecifiäśno protutijelo
JP2011530309A5 (https=)
JP2005120106A5 (https=)
FI3527070T3 (fi) Humanisoituja kevytketjuhiiriä
JP2012143232A5 (https=)
JP2011155981A5 (https=)
HRP20171194T1 (hr) Trovalentni konstrukti nanotijela protiv ljudskog respiratornog sincicijskog virusa (hrsv) za prevenciju i/ili liječenje infekcija dišnih puteva
JP2017528117A5 (https=)
JP2016196468A5 (https=)
FI3088517T3 (fi) Ihmisen Anti-IL-33 neutraloiva monoklonaalinen vasta-aine
HRP20211582T1 (hr) Protutijela specifična za tgf-beta
JP2007045828A5 (https=)
JP2007197439A5 (https=)
JP2010227108A5 (https=)
RU2018137842A (ru) Агонисты рецепторов глюкагона/glp-1 для лечения ожирения
JP2011062217A5 (https=)
CA2699834A1 (en) Improved anti-il-6 receptor antibody
JP2011004753A5 (https=)
ME02607B (me) Molekuli antitela koji imaju specifično vezivanje za humani il-13
JP2012526542A5 (https=)